[Federal Register: February 19, 1998 (Volume 63, Number 33)]
[Rules and Regulations]               
[Page 8349]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr19fe98-10]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 526 and 529

 
Animal Drugs, Feeds, and Related Products; Cephapirin Sodium for 
Intramammary Infusion; Redesignation

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
drug regulations to redesignate a section of those regulations. A 
section reflecting approval of an intramammary product is redesignated 
from certain other dosage form new animal drugs to intramammary dosage 
forms to reflect the correct designation of the product.

EFFECTIVE DATE: February 19, 1998.
FOR FURTHER INFORMATION CONTACT: David L. Gordon, Center for Veterinary 
Medicine (HFV-6), Food and Drug Administration, 7500 Standish Pl., 
Rockville, MD 20855, 301-594-1739.

SUPPLEMENTARY INFORMATION: The animal drug regulations in part 529 (21 
CFR part 529) provide for codification of certain other dosage form new 
animal drugs. The regulations in part 526 (21 CFR part 526) provide for 
codification of intramammary dosage forms. Cephapirin sodium for 
intramammary infusion was inadvertently codified as Sec. 529.365. At 
this time, the animal drug regulations are amended to redesignate 
Sec. 529.365 as Sec. 526.365.

List of Subjects

21 CFR Parts 526 and 529

    Animal drugs.
    Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
the authority delegated to the Commissioner of Food and Drugs and 
redelegated to the Center for Veterinary Medicine, 21 CFR parts 526 and 
529 are amended as follows:

PART 526--INTRAMAMMARY DOSAGE FORMS

PART 529--CERTAIN OTHER DOSAGE FORM NEW ANIMAL DRUGS

    1. The authority citations for 21 CFR parts 526 and 529 continue to 
read as follows:

    Authority: 21 U.S.C. 360b.


Sec. 529.365  [Redesignated as Sec. 526.365]

    2. Section 529.365 is redesignated as Sec. 526.365.

    Dated: February 5, 1998.
Andrew J. Beaulieau,
Deputy Director, Office of New Animal Drug Evaluation, Center for 
Veterinary Medicine.
[FR Doc. 98-4081 Filed 2-18-98; 8:45 am]
BILLING CODE 4160-01-F